Cargando…

Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine

Background: High-Definition transcranial Direct Current Stimulation (HD-tDCS) allows for non-invasive neuromodulation using an array of compact (approximately 1 cm(2) contact area) “High-Definition” (HD) electrodes, as compared to conventional tDCS (which uses two large pads that are approximately 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Guleyupoglu, Berkan, Febles, Nicole, Minhas, Preet, Hahn, Christoph, Bikson, Marom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093654/
https://www.ncbi.nlm.nih.gov/pubmed/25071548
http://dx.doi.org/10.3389/fneng.2014.00028
_version_ 1782325766012272640
author Guleyupoglu, Berkan
Febles, Nicole
Minhas, Preet
Hahn, Christoph
Bikson, Marom
author_facet Guleyupoglu, Berkan
Febles, Nicole
Minhas, Preet
Hahn, Christoph
Bikson, Marom
author_sort Guleyupoglu, Berkan
collection PubMed
description Background: High-Definition transcranial Direct Current Stimulation (HD-tDCS) allows for non-invasive neuromodulation using an array of compact (approximately 1 cm(2) contact area) “High-Definition” (HD) electrodes, as compared to conventional tDCS (which uses two large pads that are approximately 35 cm(2)). In a previous transcutaneous study, we developed and validated designs for HD electrodes that reduce discomfort over >20 min session with 2 mA electrode current. Objective: The purpose of this study was to investigate the use of a chemical pretreatment with 6% benzocaine (topical numbing agent) to further reduce subjective discomfort during transcutaneous stimulation and to allow for better sham controlled studies. Methods: Pre-treatment with 6% benzocaine was compared with control (no pretreatment) for 22 min 2 mA of stimulation, with either CCNY-4 or Lectron II electroconductive gel, for both cathodal and anodal transcutaneous (forearm) stimulation (eight different combinations). Results: Results show that for all conditions and polarities tested, stimulation with HD electrodes is safe and well tolerated and that pretreatment further reduced subjective discomfort. Conclusion: Pretreatment with a mild analgesic reduces discomfort during HD-tDCS.
format Online
Article
Text
id pubmed-4093654
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-40936542014-07-28 Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine Guleyupoglu, Berkan Febles, Nicole Minhas, Preet Hahn, Christoph Bikson, Marom Front Neuroeng Neuroscience Background: High-Definition transcranial Direct Current Stimulation (HD-tDCS) allows for non-invasive neuromodulation using an array of compact (approximately 1 cm(2) contact area) “High-Definition” (HD) electrodes, as compared to conventional tDCS (which uses two large pads that are approximately 35 cm(2)). In a previous transcutaneous study, we developed and validated designs for HD electrodes that reduce discomfort over >20 min session with 2 mA electrode current. Objective: The purpose of this study was to investigate the use of a chemical pretreatment with 6% benzocaine (topical numbing agent) to further reduce subjective discomfort during transcutaneous stimulation and to allow for better sham controlled studies. Methods: Pre-treatment with 6% benzocaine was compared with control (no pretreatment) for 22 min 2 mA of stimulation, with either CCNY-4 or Lectron II electroconductive gel, for both cathodal and anodal transcutaneous (forearm) stimulation (eight different combinations). Results: Results show that for all conditions and polarities tested, stimulation with HD electrodes is safe and well tolerated and that pretreatment further reduced subjective discomfort. Conclusion: Pretreatment with a mild analgesic reduces discomfort during HD-tDCS. Frontiers Media S.A. 2014-07-11 /pmc/articles/PMC4093654/ /pubmed/25071548 http://dx.doi.org/10.3389/fneng.2014.00028 Text en Copyright © 2014 Guleyupoglu, Febles, Minhas, Hahn and Bikson. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Guleyupoglu, Berkan
Febles, Nicole
Minhas, Preet
Hahn, Christoph
Bikson, Marom
Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine
title Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine
title_full Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine
title_fullStr Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine
title_full_unstemmed Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine
title_short Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine
title_sort reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093654/
https://www.ncbi.nlm.nih.gov/pubmed/25071548
http://dx.doi.org/10.3389/fneng.2014.00028
work_keys_str_mv AT guleyupogluberkan reduceddiscomfortduringhighdefinitiontranscutaneousstimulationusing6benzocaine
AT feblesnicole reduceddiscomfortduringhighdefinitiontranscutaneousstimulationusing6benzocaine
AT minhaspreet reduceddiscomfortduringhighdefinitiontranscutaneousstimulationusing6benzocaine
AT hahnchristoph reduceddiscomfortduringhighdefinitiontranscutaneousstimulationusing6benzocaine
AT biksonmarom reduceddiscomfortduringhighdefinitiontranscutaneousstimulationusing6benzocaine